Its activation, often triggered by tumor-associated microglia and macrophages derived cytokines such as EGF, IL-6, and SDF-1α, promotes a tumor-supportive microenvironment by enhancing glioma cell motility, invadopodia activity, and cell cycle progression. Here, CXCL12 is linked to central nervous system cancer.